Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment

Dennis Winkel*, Gijsbert H. Bol, Anita M. Werensteijn-Honingh, Martijn P.W. Intven, Wietse S.C. Eppinga, Jochem Hes, Louk M.W. Snoeren, Gonda G. Sikkes, Christa G.M. Gadellaa-van Hooijdonk, Bas W. Raaymakers, Ina M. Jürgenliemk-Schulz, Petra S. Kroon

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

2 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology